Stockreport

Northwest Biotherapeutics Announces That Construction Activities Are Under Way For the First Grade C Manufacturing Suite in the Sawston, UK Facility

NORTHWEST BIOTHRPUTCS INC  (NWBO) 
US:NASDAQ Investor Relations: nwbio.com/investors-media
PDF BETHESDA, Md., Nov. 20, 2025 /PRNewswire/ -- Northwest Biotherapeutics (OTCQB:NWBO) (the "Company" or "NWBio"), a biotechnology company developing DCVax® personalized im [Read more]